- Royce Fellowship
Shane
Mulligan
Concentration
Chemistry
Award Year
2008
Developing an Economically Viable, Targeted Drug Delivery System: Synthesis of Functionalized Polynorbornene Polymer Nanocapsules from Iron Oxide Nanoparticle Substrates
Faculty Sponsor: Amit Basu
The synthesis of polymer nanocapsules utilizing gold substrates has been demonstrated. However, the use of gold is cost prohibitive, preventing commercial use of the technology. Shane worked on creating polymer nanocapsules from affordable substrates in an economically viable manner by developing a new nanoparticle-ligand system.
Shane is an Associate at HealthCare Ventures, a Capital and Private Equity firm in Boston. Shane directs strategic, business and financial analyses for portfolio assets. He is also the Business and Corporate Development at Leap Therapeutics in Cambridge, MA.